| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/14/2022 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 142.7k | $0.73 | $103.7k | | 11/14/2022 |
| 11/01/2021 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 90.9k | $1.12 | $101.8k | | 11/01/2021 |
| 06/19/2021 | Matinas BioPharma Holdings, Inc. | MTNB | Conversion | Series B Preferred Stock | 12 | $0.50 | $6 | | 06/19/2021 |
| 06/19/2021 | Matinas BioPharma Holdings, Inc. | MTNB | Conversion | Common Stock, par value $0.0001 per share | 24k | $0.00 | $0 | | 06/19/2021 |
| 06/19/2021 | Matinas BioPharma Holdings, Inc. | MTNB | Other (acquisition) | Common Stock, par value $0.0001 per share | 4.8k | $0.00 | $0 | | 06/19/2021 |
| 06/15/2021 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 20k | $4.04 | $80.8k | | 06/15/2021 |
| 11/02/2020 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 122.6k | $0.82 | $100.5k | | 11/02/2020 |
| 06/23/2020 | Matinas BioPharma Holdings, Inc. | MTNB | Other (acquisition) | Common Stock, par value $0.0001 per share | 3.6k | $0.00 | $0 | | 06/23/2020 |
| 06/16/2020 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 14k | $5.30 | $74.2k | | 06/16/2020 |
| 12/31/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Common Stock, par value $0.0001 per share | 8.3k | $0.00 | $0 | | 12/31/2019 |
| 11/01/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 107.4k | $0.91 | $98k | | 11/01/2019 |
| 09/30/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Common Stock, par value $0.0001 per share | 29.7k | $0.00 | $0 | | 09/30/2019 |
| 08/21/2019 | Aquestive Therapeutics, Inc. | AQST | Purchase | Common Stock | 900 | $3.81 | $3.4k | | 08/19/2019 |
| 08/20/2019 | Aquestive Therapeutics, Inc. | AQST | Purchase | Common Stock | 11.3k | $3.80 | $43k | | 08/19/2019 |
| 08/19/2019 | Aquestive Therapeutics, Inc. | AQST | Purchase | Common Stock | 10.8k | $3.77 | $40.5k | | 08/19/2019 |
| 06/30/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Common Stock | 21.9k | $0.00 | $0 | | 06/30/2019 |
| 06/21/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Other (acquisition) | Common Stock, par value $0.0001 per share | 2.4k | $0.00 | $0 | | 09/30/2019 |
| 06/13/2019 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 13.4k | $4.38 | $58.5k | | 06/13/2019 |
| 03/31/2019 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Common Stock | 17.2k | $0.00 | $0 | | 03/31/2019 |
| 12/31/2018 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Common Stock | 31.5k | $0.00 | $0 | | 12/31/2018 |
| 11/01/2018 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Stock option (right to buy) | 128.3k | $0.74 | $94.9k | | 11/01/2018 |
| 10/01/2018 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Common Stock | 20.4k | $0.00 | $0 | | 10/01/2018 |
| 07/24/2018 | Aquestive Therapeutics, Inc. | AQST | Grant | Stock Option (Right to Purchase) | 26.7k | $15.00 | $400.5k | | 07/24/2018 |
| 06/29/2018 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Common Stock | 43.2k | $0.00 | $0 | | 06/29/2018 |
| 06/21/2018 | Matinas BioPharma Holdings, Inc. | MTNB | Purchase | Series B Convertible Preferred Stock | 12 | $0.50 | $6 | | 06/21/2018 |
| 03/30/2018 | Matinas BioPharma Holdings, Inc. | MTNB | Grant | Common Stock | 24.7k | $0.00 | $0 | | 03/30/2018 |
| 09/07/2017 | Matinas BioPharma Holdings, Inc. | MTNB | Purchase | Common Stock | 5k | $1.29 | $6.4k | | 09/07/2017 |
| 06/05/2017 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 2k | $43.32 | $85.2k | | 06/05/2017 |
| 05/15/2017 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 20k | $51.20 | $1M | | 05/15/2017 |
| 05/15/2017 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 20k | $5.49 | $109.8k | | 05/15/2017 |
| 01/17/2017 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 15k | $38.39 | $576k | | 01/17/2017 |
| 01/17/2017 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 17.6k | $5.49 | $96.8k | | 01/17/2017 |
| 01/17/2017 | Pacira BioSciences, Inc. | PCRX | Sale | Common Stock | 5k | $38.97 | $194.7k | | 01/17/2017 |
| 01/17/2017 | Pacira BioSciences, Inc. | PCRX | Exercise | Stock Option (Right to Buy) | 2.4k | $1.61 | $3.8k | | 01/17/2017 |
| 12/07/2016 | Pacira BioSciences, Inc. | PCRX | Grant | Stock Option (Right to Buy) | 20k | $32.35 | $647k | | 12/07/2016 |
|